AR and metastatic neoplasm: Using the IHC (Figure 2A) to evaluate the PSA expression in primary and metastatic tumors, our data demonstrated that PSA expression was decreased in higher Gleason grade tumors, which is consistent with observations that during aggressive cancer growth, prostate tumors lower dependency on AR regulation [18].